logo

ABT

Abbott Laboratories·NYSE
--
--(--)
--
--(--)

ABT fundamentals

Abbott Laboratories (ABT) released its earnings on Jan 22, 2026: revenue was 11.46B (YoY +4.43%), missed estimates; EPS was 1.5 (YoY +11.94%), beat estimates.
Revenue / YoY
11.46B
+4.43%
EPS / YoY
1.5
+11.94%
Report date
Jan 22, 2026
ABT Earnings Call Summary for Q4,2025
  • 2026 Growth Targets: 7% organic sales midpoint, 10% EPS growth.
  • Nutrition Turnaround: 8 new product launches; 2026H2 return to growth.
  • Medical Devices Strength: CGM ($7.1B+ annual sales), EPD (7%+ growth), Rhythm Management (12%+).
  • Exact Sciences Acquisition: Enters $10B+ cancer diagnostics market.
  • Key Risks: Nutrition volume headwinds, China VBP implementation.
  • Margin Expansion: 50-70bps annual operating margin improvement.
EPS
Revenue

Revenue & Expenses

ABT has released its 2025 Q4 earnings report, with revenue of 11.46B, reflecting a YoY change of 4.42%, and net profit of 1.78B, showing a YoY change of -80.76%. The Sankey diagram below clearly presents ABT's revenue sources and cost distribution.

Key Indicators

Abbott Laboratories (ABT) key financial stats and ratios, covering profitability, financial health, and leverage.
Abbott Laboratories (ABT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Abbott Laboratories (ABT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Abbott Laboratories (ABT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Abbott Laboratories (ABT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Abbott Laboratories (ABT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield